Enhancing the immunogenicity of tumour lysate-loaded dendritic cell vaccines by conjugation to virus-like particles.
about
Cross-presentation of viral antigens in dribbles leads to efficient activation of virus-specific human memory T cellsNovel function for the p38-MK2 signaling pathway in circulating CD1c+ (BDCA-1+) myeloid dendritic cells from healthy donors and advanced cancer patients; inhibition of p38 enhances IL-12 whilst suppressing IL-10.Delivery System of CpG Oligodeoxynucleotides through Eliciting an Effective T cell Immune Response against Melanoma in Mice.Tumor lysate-loaded biodegradable microparticles as cancer vaccines.Antigen delivery by virus-like particles for immunotherapeutic vaccination.Secretion and assembly of calicivirus-like particles in high-cell-density yeast fermentations: strategies based on a recombinant non-specific BPTI-Kunitz-type protease inhibitor.Assessing T-cell responses in anticancer immunotherapy: Dendritic cells or myeloid-derived suppressor cells?Use of antigen-primed dendritic cells for inducing antitumor immune responses in vitro in patients with non-small cell lung cancer.Oncolysate-loaded Escherichia coli bacterial ghosts enhance the stimulatory capacity of human dendritic cells.
P2860
Q33613138-2F62F1B9-A49C-41D8-987C-4BB5194729A9Q34983989-D1750B6C-6EF6-4E29-A3DB-095783913041Q36563884-32F929CC-786E-4B6D-A523-5D9E3223B907Q37670779-29A4AC9D-5285-404A-8FC7-27F36CA2F6D2Q38285854-00EBBC38-ACE9-4716-96BE-5E185BFBED70Q42181296-DBA610F4-3FDE-407B-9E8E-30EF98752538Q42910288-DBDFE4F1-FCBC-40E2-A375-F6EA11999160Q49334976-1A635009-39BF-40B8-987D-5F913E57C1A0Q50545957-4FF5BBC9-8270-478D-8904-C033EDEE1183
P2860
Enhancing the immunogenicity of tumour lysate-loaded dendritic cell vaccines by conjugation to virus-like particles.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Enhancing the immunogenicity o ...... ation to virus-like particles.
@ast
Enhancing the immunogenicity o ...... ation to virus-like particles.
@en
type
label
Enhancing the immunogenicity o ...... ation to virus-like particles.
@ast
Enhancing the immunogenicity o ...... ation to virus-like particles.
@en
prefLabel
Enhancing the immunogenicity o ...... ation to virus-like particles.
@ast
Enhancing the immunogenicity o ...... ation to virus-like particles.
@en
P2093
P2860
P356
P1154
2-s2.0-84855350632
P1476
Enhancing the immunogenicity o ...... gation to virus-like particles
@en
P2093
A A Melcher
F Errington-Mais
P2860
P2888
P356
10.1038/BJC.2011.538
P407
P5530
P577
2011-12-01T00:00:00Z
P5875
P6179
1026969559